Bitter Dissent Shreds Rehearing Denial In Md. Drug Price Row
The Fourth Circuit on Tuesday refused to revisit its nullification of Maryland's ban on price gouging for generic drugs, drawing a fiery dissent that alleged judicial overreach and appeared to provide...To view the full article, register now.
Already a subscriber? Click here to view full article